JPMorgan Chase Financial Files 424B2 Prospectus on 3/24/26

TL;DR

**JPM Financial just filed a 424B2, likely new securities coming.**

AI Summary

JPMorgan Chase Financial Co. LLC filed a 424B2 prospectus on March 24, 2026, which is a pricing supplement for a previously registered offering. This filing, under Act 33 and File No. 333-270004-01, indicates that JPMorgan Chase & Co. (CIK: 0000019617) is the parent company. For investors, this means JPMorgan Chase Financial Co. LLC is likely issuing new securities, potentially debt, which could impact the parent company's capital structure and future earnings if the terms are unfavorable or if the market reacts poorly to the offering.

Why It Matters

This filing signals a potential new securities offering by JPMorgan Chase Financial Co. LLC, which could affect the parent company's financial health and stock valuation.

Risk Assessment

Risk Level: medium — The filing itself is administrative, but the underlying offering it represents could introduce market risk or impact the company's debt load.

Analyst Insight

Investors should monitor for the specific terms of the securities being offered, such as interest rates, maturity dates, and any covenants, as these details will be crucial for assessing the impact on JPMorgan Chase & Co.'s financial health.

Key Numbers

• 333-270004-01 — File Number (Identifies the specific registration statement for the offering by JPMorgan Chase Financial Co. LLC)
• 333-270004 — File Number (Identifies the specific registration statement for the offering by JPMORGAN CHASE & CO)
• 696350 — Size in bytes (Size of the PRICING SUPPLEMENT document (ea0283230-01_424b2.htm))

Key Players & Entities

• JPMorgan Chase Financial Co. LLC (company) — Filer of the 424B2 prospectus
• JPMORGAN CHASE & CO (company) — Parent company of the filer
• 0001665650 (person) — CIK of JPMorgan Chase Financial Co. LLC
• 0000019617 (person) — CIK of JPMORGAN CHASE & CO
• 2026-03-24 (date) — Filing date of the 424B2

FAQ

Key Financial Figures

• $3,155,000 — Company LLC Structured Investments $3,155,000 Uncapped Accelerated Barrier Notes Li
• $1,000 — ribed below. Minimum denominations of $1,000 and integral multiples thereof The no
• $3 — roceeds to Issuer Per note $1,000 $3 $997 Total $3,155,000 $9,465
• $997 — ds to Issuer Per note $1,000 $3 $997 Total $3,155,000 $9,465 $3,145,
• $9,465 — ,000 $3 $997 Total $3,155,000 $9,465 $3,145,535 (1) See "Supplemental Us
• $3,145,535 — $997 Total $3,155,000 $9,465 $3,145,535 (1) See "Supplemental Use of Proceeds
• $3.00 — pay all of the selling commissions of $3.00 per $1,000 principal amount note it rec
• $975.70 — en the terms of the notes were set, was $975.70 per $1,000 principal amount note. See
• $2,882.000 — aturity 180.00 80.00% 188.2000% $2,882.000 170.00 70.00% 164.6750% $2,646.
• $2,646.750 — 882.000 170.00 70.00% 164.6750% $2,646.750 160.00 60.00% 141.1500% $2,411.
• $2,411.500 — 646.750 160.00 60.00% 141.1500% $2,411.500 150.00 50.00% 117.6250% $2,176.
• $2,176.250 — 411.500 150.00 50.00% 117.6250% $2,176.250 140.00 40.00% 94.1000% $1,941.0
• $1,941.000 — ,176.250 140.00 40.00% 94.1000% $1,941.000 130.00 30.00% 70.5750% $1,705.7
• $1,705.750 — ,941.000 130.00 30.00% 70.5750% $1,705.750 120.00 20.00% 47.0500% $1,470.5
• $1,470.500 — ,705.750 120.00 20.00% 47.0500% $1,470.500 110.00 10.00% 23.5250% $1,235.2

Filing Documents

• ea0283230-01_424b2.htm (424B2) — 680KB
• ea028323001_ex-filingfees.htm (EX-FILING FEES) — 4KB
• bg1.jpg (GRAPHIC) — 264KB
• bg2.jpg (GRAPHIC) — 257KB
• bg3.jpg (GRAPHIC) — 478KB
• bg4.jpg (GRAPHIC) — 364KB
• bg5.jpg (GRAPHIC) — 37KB
• bg6.jpg (GRAPHIC) — 116KB
• bg7.jpg (GRAPHIC) — 497KB
• bg8.jpg (GRAPHIC) — 186KB
• bg9.jpg (GRAPHIC) — 292KB
• bga.jpg (GRAPHIC) — 37KB
• 0001213900-26-033429.txt ( ) — 2355KB
• ea028323001_ex-filingfees_htm.xml (XML) — 2KB

From the Filing

SUPPLEMENT March 20, 2026 Registration Statement Nos. 333-270004 and 333- 270004 -01; Rule 424(b)(2) Pricing supplement to product supplement no. 4-I dated April 13, 2023, underlying supplement no. 1-I dated April 13, 2023, the prospectus and prospectus supplement, each dated April 13, 2023, and the prospectus addendum dated June 3, 2024 JPMorgan Chase Financial Company LLC Structured Investments $3,155,000 Uncapped Accelerated Barrier Notes Linked to the Lesser Performing of the EURO STOXX 50 Index and the STOXX Europe 600 Index due March 25, 2030 Fully and Unconditionally Guaranteed by JPMorgan Chase & Co. The notes are designed for investors who seek an uncapped return of 2.3525 times any appreciation of the lesser performing of the EURO STOXX 50 Index and the STOXX Europe 600 Index, which we refer to as the Indices, at maturity. Investors should be willing to forgo interest and dividend payments and be willing to lose some or all of their principal amount at maturity. The notes are unsecured and unsubordinated obligations of JPMorgan Chase Financial Company LLC, which we refer to as JPMorgan Financial, the payment on which is fully and unconditionally guaranteed by JPMorgan Chase & Co. Any payment on the notes is subject to the credit risk of JPMorgan Financial, as issuer of the notes, and the credit risk of JPMorgan Chase & Co., as guarantor of the notes. Payments on the notes are not linked to a basket composed of the Indices. Payments on the notes are linked to the performance of each of the Indices individually, as described below. Minimum denominations of $1,000 and integral multiples thereof The notes priced on March 20, 2026 and are expected to settle on or about March 25, 2026. CUSIP: 46660R7B4 Investing in the notes involves a number of risks. See "Risk Factors" beginning on page S -2 of the accompanying prospectus supplement, Annex A to the accompanying prospectus addendum, "Risk Factors" beginning on page PS -11 of the accompanying product supplement and "Selected Risk Considerations" beginning on page PS -3 of this pricing supplement. Neither the Securities and Exchange Commission (the "SEC") nor any state securities commission has approved or disapproved of the notes or passed upon the accuracy or the adequacy of this pricing supplement or the accompanying product supplement, underlying supplement, prospectus supplement, prospectus and prospectus addendum. Any representation to the contrary is a criminal offense. Price to Public (1) Fees and Commissions (2) Proceeds to Issuer Per note $1,000 $3 $997 Total $3,155,000 $9,465 $3,145,535 (1) See "Supplemental Use of Proceeds" in this pricing supplement for information about the components of the price to public of the notes. (2) J.P. Morgan Securities LLC, which we refer to as JPMS, acting as agent for JPMorgan Financial, will pay all of the selling commissions of $3.00 per $1,000 principal amount note it receives from us to other affiliated or unaffiliated dealers. See "Plan of Distr ibution (Conflicts of Interest)" in the accompanying product supplement. The estimated value of the notes, when the terms of the notes were set, was $975.70 per $1,000 principal amount note. See "The Estimated Value of the Notes" in this pricing supplement for additional information. The notes are not bank deposits, are not insured by the Federal Deposit Insurance Corporation or any other governmental agenc y and are not obligations of, or guaranteed by, a bank. PS -1 | Structured Investments Uncapped Accelerated Barrier Notes Linked to the Lesser Performing of the EURO STOXX 50 Index and the STOXX Europe 600 Index Key Terms Issuer: JPMorgan Chase Financial Company LLC, a direct, wholly owned finance subsidiary of JPMorgan Chase & Co. Guarantor: JPMorgan Chase & Co. Indices: The EURO STOXX 50 Index (Bloomberg ticker: SX5E) and the STOXX Europe 600 Index (Bloomberg ticker: SXXP) (each an "Index" and collectively, the "Indices") Upside Leverage Factor: 2.3525 Barrier Amount: With respect to each Index, 75.00% of its Initial Value, which is 4,125.96 for the EURO STOXX 50 Index and 429.96 for the STOXX Europe 600 Index Pricing Date: March 20, 2026 Original Issue Date (Settlement Date): On or about March 25, 2026 Observation Date*: March 20, 2030 Maturity Date*: March 25, 2030 * Subject to postponement in the event of a market disruption event and as described under "General Terms of Notes — Postponement of a Determination Date — Notes Linked to Multiple Underlyings" and "General Terms of Notes — Postponement of a Payment Date" in the accompanying product supplement or early acceleration in the event of a change- in - law event as described under "General Terms of Notes — Consequences of a Change- in - Law Event" in the accompanying product supplement and "Selected Risk Considerations — We May Accelerate You

View Full Filing

View this 424B2 filing on SEC EDGAR